- Trevi Therapeutics to Participate in Upcoming Investor and Healthcare Events
- Trevi Therapeutics to Participate in Upcoming Conferences
- Trevi Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
- Trevi Therapeutics to Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 7, 2024
Key statistics
On Monday, Trevi Therapeutics Inc (TRVI:NMQ) closed at 2.81, -29.75% below its 52-week high of 4.00, set on Mar 21, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.79 |
---|---|
High | 2.85 |
Low | 2.71 |
Bid | 1.14 |
Offer | 2.92 |
Previous close | 2.81 |
Average volume | 252.32k |
---|---|
Shares outstanding | 70.44m |
Free float | 69.53m |
P/E (TTM) | -- |
Market cap | 200.04m USD |
EPS (TTM) | -0.338 USD |
Data delayed at least 15 minutes, as of Jul 22 2024 21:00 BST.
More ▼